# Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

Source: https://onco.cc/trials/nct03003065/  
OnCo record `nct03003065` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Temoporfin in Extrahepatic cholangiocarcinoma, run by Chinese University of Hong Kong, completed.

## Summary

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers is a phase 2 interventional study registered as NCT03003065 by Chinese University of Hong Kong, with 10 participants recorded, started 2014-03-28 and reaching its primary completion in 2023-04-12. Interventions recorded: Temoporfin. Conditions recorded: Cholangiocarcinoma, Tumor, Klatskin Tumor.

Linked to the drug Temoporfin because the registry names it among its interventions and Extrahepatic cholangiocarcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03003065
- Phase: 2
- Setting: Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)
- Sponsor: Chinese University of Hong Kong
- Enrolled: 10

## Sources

- ClinicalTrials.gov NCT03003065: https://clinicaltrials.gov/study/NCT03003065

## Connected records

- cancers: [Extrahepatic cholangiocarcinoma (perihilar and distal)](https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/)
- drugs: [Temoporfin](https://onco.cc/drugs/temoporfin/)

---
JSON: https://onco.cc/api/v1/entities/nct03003065.json